Diagnosis, Treatment, and Prevention of Venous Thromboembolism in Pregnancy

References

• . Anderson BS, Steffensen FH, Sorensen HT,. The cumulative incidence of venous thromboembolism during pregnancy and puerperium—an 11 year Danish population-based study of 63,000 pregnancies. Acta Obstet Gynecol Scand. 198;77(2):170–173
   PubMedGoogle Scholar
• . Heit JA, Kobbervig CE, James AH,. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–706
   PubMed Web of Science ®Google Scholar
• . Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008;359(19):2025–2033
   PubMed Web of Science ®Google Scholar
• . Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632–637
   PubMed Web of Science ®Google Scholar
• . Kamel H, Navi BB, Sriram N,. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–1315
   PubMed Web of Science ®Google Scholar
• . Gherman RB, Goodwin TM, Leung B,. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999;94(5 Pt 1):730–734
   PubMed Web of Science ®Google Scholar
• . Centre for Maternal and Child Enquiries (CMACE). Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118( Suppl 1):1–203
   Google Scholar
• . Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116(6):1302–1309
   PubMed Web of Science ®Google Scholar
• . Rodger MA, Walker M, Wells PS. Diagnosis and treatment of venous thromboembolism in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):279–296
   PubMedGoogle Scholar
• . Hague WM, Dekker GA. Risk factors for thrombosis in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):197–210
   PubMedGoogle Scholar
• . Gibson PS, Powrie R. Anticoagulants and pregnancy: when are they safe? Cleve Clin J Med. 2009;76(2):113–127
   PubMedGoogle Scholar
• . James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193(1):216–219
   PubMed Web of Science ®Google Scholar
• . Chan WS, Spencer FA, Ginsberg JS. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ. 2010;182(7):657–660
   PubMed Web of Science ®Google Scholar
• . Greer IA. Prevention of venous thromboembolism in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):261–278
   PubMedGoogle Scholar
• . Gerhardt A, Scharf RE, Beckmann MW,. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374–380
   PubMed Web of Science ®Google Scholar
• . American College of Obstetricians and Gynecologists Women's Health Care Physicians. ACOG Practice bulletin no. 138: Inherited thrombophilias in pregnancy. Obstet Gynecol. 2013;122(3):706–717
   PubMedGoogle Scholar
• . Kujovich JL, Alving BM. Management of thrombophilia and antiphospholipid syndrome during pregnancy. In: Kitchens CS, Alving BM, Kessler Craig M, eds. Consultative Hemostasis and Thrombosis, 2nd ed. Philadelphia: Elsevier; 2007:593–609
   Google Scholar
• . Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematology Am Soc Hematol Educ Program. 2012;2012:203–207
   PubMed Web of Science ®Google Scholar
• . James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–1315
   PubMed Web of Science ®Google Scholar
• . Jacobsen AF, Skjeldestat FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case control study. Am J Obstet Gynecol. 2008;198(2):233–234
   PubMedGoogle Scholar
• . Sultan AA, Tata LJ, West J,. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood. 2013;121(19):3953–3961
   PubMedGoogle Scholar
• . Refuerzo JS, Hechtman JL, Redman ME, Whitty JE. Venous thromboembolism during pregnancy. Clinical suspicion warrants evaluation. J Reprod Med. 2003;48(10):767–770
   PubMedGoogle Scholar
• . Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med. 1998;128(8):663–677
   PubMed Web of Science ®Google Scholar
• . Fraser DG, Moody AR, Morgan PS,. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med. 2002;136(2):89–98
   PubMedGoogle Scholar
• . Chan WS, Spencer FA, Lee AY,. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CMAJ. 2013;185(4):E194–E200
   Google Scholar
• . Revel MP, Cohen S, Sanchez O,. Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography? Radiology. 2011;258(2):590–598
   PubMedGoogle Scholar
• . Cahill AG, Stout MJ, Macones GA, Bhalla S. Diagnosing pulmonary embolism in pregnancy using computed-tomographic angiography or ventilation-perfusion. Obstet Gynecol. 2009;114(1):124–129
   PubMedGoogle Scholar
• . Winer-Muram HT, Boone JM, Brown HL,. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology. 2002;224(2):487–492
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Radiation and pregnancy: a fact sheet for clinicians. www.bt.cdc.gov/radiation/prenatalphysician.asp. Accessed August 20, 2014
   Google Scholar
• . Bourjelly G, Chalhoub M, Phornphutkul C,. Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero. Radiology. 2010;256(3):744–750
   PubMedGoogle Scholar
• . Leung AN, Bull TM, Jaeschke R,. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med. 2011;184(10):1200–1208
   PubMedGoogle Scholar
• . Chan WS, Chunilal S, Lee A,. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med. 2007;147(3):165–170
   PubMedGoogle Scholar
• . To MS, Hunt BJ, Nelson-Piercy C. A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy. J Obstet Gynaecol. 2008;28(2):222–223
   PubMedGoogle Scholar
• . Chan WS, Lee A, Spencer FA,. Predicting deep venous thrombosis in pregnancy: out in “LEFt” field? Ann Intern Med. 2009;151(2):85–92
   PubMedGoogle Scholar
• . Hirsh J, Warkentin TE, Shaughnessy SG,. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119( 1 Suppl):64S–94S
   PubMed Web of Science ®Google Scholar
• . Cosmi B, Palareti G. Old and new heparins. Thromb Res. 2012;129(3):388–391
   PubMed Web of Science ®Google Scholar
• . Van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2004;4:CD001100
   Google Scholar
• . Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401–407
   PubMed Web of Science ®Google Scholar
• . Romualdi E, Dentali F, Rancan E,. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2013;11(2):270–281
   PubMed Web of Science ®Google Scholar
• . Battinelli EM, Marshall A, Connors JM. The role of thrombophilia in pregnancy. Thrombosis. 2013;2013:516420
   PubMedGoogle Scholar
• . Bates SM, Greer IA, Middeldorp S,. VTE, Thrombophilia, antithrombotic therapy, and pregnancy. Chest. 2012;141( 2 Suppl):e691S–736S
   PubMed Web of Science ®Google Scholar
• . Voke J, Keidan J, Pavord S,. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey. Br J Haematol. 2007;139(4):545–558
   PubMedGoogle Scholar
• . Knight M; UK Obstetric Surveillance System. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG. 2008;115(4):453–461
   PubMed Web of Science ®Google Scholar
• . Rodie VA, Thomson AJ, Stewart FM,. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG. 2002;109(9):1020–1024
   PubMed Web of Science ®Google Scholar
• . Young SK, Al-Mondhiry HA, Vaida SJ,. Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature. Pharmacotherapy. 2008;28(12):1531–1536
   PubMedGoogle Scholar
• . Ekbatani A, Asaro LR, Malinow AM. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia. Int J Obstet Anesth. 2010;19(1):82–87
   PubMedGoogle Scholar
• . Ciurzynski M, Jankowski K, Pietrzak B,. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit. 2011;17(5):CS56–CS59
   PubMedGoogle Scholar
• . Holst J, Lindblad B, Berggvist D,. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers. Blood Coagul Fibrinolysis. 1994;5(5):795–803
   PubMedGoogle Scholar
• . Lagrange F, Vergnes C, Brun JL,. Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro. Thromb Haemost. 2002;87(5):831–835
   PubMed Web of Science ®Google Scholar
• . Dempfle CE. Minor transplacental passage of fondaparinux in vivo. N Engl J Med. 2004;350(18):1914–1915
   PubMed Web of Science ®Google Scholar
• . Fareed J, Thethi I, Hoppensteadt D. Old versus new oral anticoagulants: focus on pharmacology. Annu Rev Pharmacol Toxicol. 2012;52:79–99
   PubMed Web of Science ®Google Scholar
• . Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68(1):122–140
   PubMed Web of Science ®Google Scholar
• . Schaefer C, Hannemann D, Meister R,. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006;95(6):959–957
   Google Scholar
• . Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160(2):191–196
   PubMedGoogle Scholar
• . Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation. 1984;70(3 Pt 2):169–177
   Google Scholar
• . Iturbe-Alessio I, Fonseca MC, Mutchinik O,. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med. 1986;315(22):1390–1393
   PubMed Web of Science ®Google Scholar
• . Wesseling J, Van Driel D, Heymans HS,. Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost. 2001;85(4):609–613
   PubMed Web of Science ®Google Scholar
• . Lee HC, Cho SY, Lee HJ,. Warfarin-associated fetal intracranial hemorrhage: a case report. J Korean Med Sci. 2003;18(5):764–767
   PubMedGoogle Scholar
• . Pati S, Helmbrecht GD. Congenital schizencephaly associated with in utero warfarin exposure. Reprod Toxicol. 1994;8(2):115–120
   PubMedGoogle Scholar
• . Bapat P, Kedar R, Lubetsky A,. Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta. Obstet Gynecol. 2014;123(6):1256–1261
   PubMed Web of Science ®Google Scholar
• . Anderson DR, Ginsberg GS, Burrows R, Brill-Edwards P. Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb Haemost. 1991;65(3):248–250
   PubMedGoogle Scholar
• . Horlocker TT, Wedel DJ, Rowlingson JC,. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (3rd edition). Reg Anesth Pain Med. 2010;35(1):64–101
   PubMed Web of Science ®Google Scholar
• . Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood. 2011;118(20):5394–5400
   PubMedGoogle Scholar
• . Richter C, Sitzman J, Lang P,. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol. 2001;52(6):708–710
   PubMedGoogle Scholar
• . GlaxoSmithKline. Product monograph: Arixtra. 2013. http://www.gsk.ca/english/docs-pdf/product-monographs/Arixtra.pdf. Accessed August 5, 2014
   Google Scholar
• . Holden EL, Ranu H, Sheth A,. Thrombolysis for massive pulmonary embolism in pregnancy—a report of three cases and follow up over a two year period. Thromb Res. 2011;127(1):58–59
   PubMed Web of Science ®Google Scholar
• . Te Raa GD, Ribbert LS, Snijder RJ, Biesma DH. Treatment options in massive pulmonary embolism during pregnancy: a case report and review of literature. Thromb Res. 2009;124(1):1–5
   PubMed Web of Science ®Google Scholar
• . Lima F, Khamashta MA, Buchanan NM,. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 1996;14(2):131–136
   PubMed Web of Science ®Google Scholar
• . Branch DW, Silver RM, Blackwell JL,. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992;80(4):614–620
   PubMed Web of Science ®Google Scholar
• . Galli M, Barbui T. Antiphospholipid antibodies in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):211–225
   PubMedGoogle Scholar
• . Holers VM, Girardi G, Mo L,. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med. 2002;195(2):211–220
   PubMed Web of Science ®Google Scholar
• . Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314(7076):253–257
   PubMed Web of Science ®Google Scholar
• . Franklin RD, Kutteh WH. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APAP positive population. Hum Reprod. 2002;17(11):2981–2985
   PubMedGoogle Scholar
• . Goel N, Tuli A, Choudhry R. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies. Med Sci Monit. 2006;12(3):CR132–CR136
   PubMed Web of Science ®Google Scholar
• . Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174(5):1584–1589
   PubMed Web of Science ®Google Scholar
• . Mak A, Cheung MW, Cheak AA,. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology. 2010;49(2):281–288
   PubMed Web of Science ®Google Scholar
• . Stephenson MD, Ballem PJ, Tsang P,. Treatment of antiphospholipid antibody síndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can. 2004;26(8):729–734
   PubMedGoogle Scholar
• . Noble LS, Kutteh WH, Lashey N,. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril. 2005;83(3):684–690
   PubMedGoogle Scholar
• . Fouda UM, Saved AM, Abdou AM,. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. Int J Gynaecol Obstet. 2011;112(3):211–215
   PubMed Web of Science ®Google Scholar